BusinessUS Highlights IP Concerns in India's Pharmaceutical Sector
The US government identifies India as one of six countries raising concerns about intellectual property rights protection and enforcement, particularly in the pharmaceutical sector, according to the USTR Special 301 report. Pharma exporters suggest that incentivizing formulations could help shield the sector from these challenges.
The New Indian Express·


